Global Parkinson’s Disease Drugs Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Parkinson’s Disease Drugs

• 1.1 Definition of Parkinson’s Disease Drugs
• 1.2 Parkinson’s Disease Drugs Segment by Type
  • 1.2.1 Global Parkinson’s Disease Drugs Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Oral
  • 1.2.3 Transdermal
  • 1.2.4 Subcutaneous
  • 1.2.5 Intestinal Infusion
• 1.3 Parkinson’s Disease Drugs Segment by Applications
  • 1.3.1 Global Parkinson’s Disease Drugs Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital Pharmacy
  • 1.3.3 Retail Pharmacy
  • 1.3.4 Online Pharmacy
• 1.4 Global Parkinson’s Disease Drugs Overall Market
  • 1.4.1 Global Parkinson’s Disease Drugs Revenue (2014-2025)
  • 1.4.2 Global Parkinson’s Disease Drugs Production (2014-2025)
  • 1.4.3 North America Parkinson’s Disease Drugs Status and Prospect (2014-2025)
  • 1.4.4 Europe Parkinson’s Disease Drugs Status and Prospect (2014-2025)
  • 1.4.5 China Parkinson’s Disease Drugs Status and Prospect (2014-2025)
  • 1.4.6 Japan Parkinson’s Disease Drugs Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Parkinson’s Disease Drugs Status and Prospect (2014-2025)
  • 1.4.8 India Parkinson’s Disease Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Parkinson’s Disease Drugs
• 2.3 Manufacturing Process Analysis of Parkinson’s Disease Drugs
• 2.4 Industry Chain Structure of Parkinson’s Disease Drugs

3 Development and Manufacturing Plants Analysis of Parkinson’s Disease Drugs

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Parkinson’s Disease Drugs Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Parkinson’s Disease Drugs
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Parkinson’s Disease Drugs Production and Capacity Analysis
• 4.2 Parkinson’s Disease Drugs Revenue Analysis
• 4.3 Parkinson’s Disease Drugs Price Analysis
• 4.4 Market Concentration Degree

5 Parkinson’s Disease Drugs Regional Market Analysis

• 5.1 Parkinson’s Disease Drugs Production by Regions
  • 5.1.1 Global Parkinson’s Disease Drugs Production by Regions
  • 5.1.2 Global Parkinson’s Disease Drugs Revenue by Regions
• 5.2 Parkinson’s Disease Drugs Consumption by Regions
• 5.3 North America Parkinson’s Disease Drugs Market Analysis
  • 5.3.1 North America Parkinson’s Disease Drugs Production
  • 5.3.2 North America Parkinson’s Disease Drugs Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Parkinson’s Disease Drugs Import and Export
• 5.4 Europe Parkinson’s Disease Drugs Market Analysis
  • 5.4.1 Europe Parkinson’s Disease Drugs Production
  • 5.4.2 Europe Parkinson’s Disease Drugs Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Parkinson’s Disease Drugs Import and Export
• 5.5 China Parkinson’s Disease Drugs Market Analysis
  • 5.5.1 China Parkinson’s Disease Drugs Production
  • 5.5.2 China Parkinson’s Disease Drugs Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Parkinson’s Disease Drugs Import and Export
• 5.6 Japan Parkinson’s Disease Drugs Market Analysis
  • 5.6.1 Japan Parkinson’s Disease Drugs Production
  • 5.6.2 Japan Parkinson’s Disease Drugs Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Parkinson’s Disease Drugs Import and Export
• 5.7 Southeast Asia Parkinson’s Disease Drugs Market Analysis
  • 5.7.1 Southeast Asia Parkinson’s Disease Drugs Production
  • 5.7.2 Southeast Asia Parkinson’s Disease Drugs Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Parkinson’s Disease Drugs Import and Export
• 5.8 India Parkinson’s Disease Drugs Market Analysis
  • 5.8.1 India Parkinson’s Disease Drugs Production
  • 5.8.2 India Parkinson’s Disease Drugs Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Parkinson’s Disease Drugs Import and Export

6 Parkinson’s Disease Drugs Segment Market Analysis (by Type)

• 6.1 Global Parkinson’s Disease Drugs Production by Type
• 6.2 Global Parkinson’s Disease Drugs Revenue by Type
• 6.3 Parkinson’s Disease Drugs Price by Type

7 Parkinson’s Disease Drugs Segment Market Analysis (by Application)

• 7.1 Global Parkinson’s Disease Drugs Consumption by Application
• 7.2 Global Parkinson’s Disease Drugs Consumption Market Share by Application (2014-2019)

8 Parkinson’s Disease Drugs Major Manufacturers Analysis

• 8.1 Novartis
  • 8.1.1 Novartis Parkinson’s Disease Drugs Production Sites and Area Served
  • 8.1.2 Novartis Product Introduction, Application and Specification
  • 8.1.3 Novartis Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 F. Hoffmann-La Roche
  • 8.2.1 F. Hoffmann-La Roche Parkinson’s Disease Drugs Production Sites and Area Served
  • 8.2.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
  • 8.2.3 F. Hoffmann-La Roche Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 AbbVie
  • 8.3.1 AbbVie Parkinson’s Disease Drugs Production Sites and Area Served
  • 8.3.2 AbbVie Product Introduction, Application and Specification
  • 8.3.3 AbbVie Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Teva Pharmaceutical Industries
  • 8.4.1 Teva Pharmaceutical Industries Parkinson’s Disease Drugs Production Sites and Area Served
  • 8.4.2 Teva Pharmaceutical Industries Product Introduction, Application and Specification
  • 8.4.3 Teva Pharmaceutical Industries Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 UCB Inc.
  • 8.5.1 UCB Inc. Parkinson’s Disease Drugs Production Sites and Area Served
  • 8.5.2 UCB Inc. Product Introduction, Application and Specification
  • 8.5.3 UCB Inc. Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 STADA Arzneimittel
  • 8.6.1 STADA Arzneimittel Parkinson’s Disease Drugs Production Sites and Area Served
  • 8.6.2 STADA Arzneimittel Product Introduction, Application and Specification
  • 8.6.3 STADA Arzneimittel Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 GlaxoSmithKline
  • 8.7.1 GlaxoSmithKline Parkinson’s Disease Drugs Production Sites and Area Served
  • 8.7.2 GlaxoSmithKline Product Introduction, Application and Specification
  • 8.7.3 GlaxoSmithKline Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Valeant Pharmaceuticals International
  • 8.8.1 Valeant Pharmaceuticals International Parkinson’s Disease Drugs Production Sites and Area Served
  • 8.8.2 Valeant Pharmaceuticals International Product Introduction, Application and Specification
  • 8.8.3 Valeant Pharmaceuticals International Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Merck
  • 8.9.1 Merck Parkinson’s Disease Drugs Production Sites and Area Served
  • 8.9.2 Merck Product Introduction, Application and Specification
  • 8.9.3 Merck Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Impax Laboratories
  • 8.10.1 Impax Laboratories Parkinson’s Disease Drugs Production Sites and Area Served
  • 8.10.2 Impax Laboratories Product Introduction, Application and Specification
  • 8.10.3 Impax Laboratories Parkinson’s Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Parkinson’s Disease Drugs Market

• 9.1 Global Parkinson’s Disease Drugs Market Trend Analysis
  • 9.1.1 Global Parkinson’s Disease Drugs Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Parkinson’s Disease Drugs Regional Market Trend
  • 9.2.1 North America Parkinson’s Disease Drugs Forecast 2019-2025
  • 9.2.2 Europe Parkinson’s Disease Drugs Forecast 2019-2025
  • 9.2.3 China Parkinson’s Disease Drugs Forecast 2019-2025
  • 9.2.4 Japan Parkinson’s Disease Drugs Forecast 2019-2025
  • 9.2.5 Southeast Asia Parkinson’s Disease Drugs Forecast 2019-2025
  • 9.2.6 India Parkinson’s Disease Drugs Forecast 2019-2025
• 9.3 Parkinson’s Disease Drugs Market Trend (Product Type)
• 9.4 Parkinson’s Disease Drugs Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Parkinson’s Disease Drugs Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List